GlassScriptPhysician profile
Elwyn C Cabebe
NPI 1821067281
$1,313.67
in general payments reported to CMS, 2019-2025
17 companies · $543 in 2025
The $543 reported for 2025 was less than what a typical Medical Oncology provider received nationally (typical 2025 total: $1,158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $437 · 2020: $63.68 · 2021: $25.85 · 2023: $70.85 · 2024: $174 · 2025: $543.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $769 · Education: $18.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $769.23 |
| Education | $18.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $689.83 | 2019-2025 | Lynparza |
| Amgen INC. | $100.23 | 2019 | |
| Novartis Pharmaceuticals Corporation | $66.70 | 2019 | |
| Foundation Medicine, INC. | $64.49 | 2019-2023 | |
| Pfizer INC. | $60.81 | 2019-2024 | |
| Gilead Sciences, INC. | $43.52 | 2019-2021 | |
| Adc Therapeutics America, INC. | $40.39 | 2023 | |
| Emd Serono, INC. | $39.57 | 2019-2020 | |
| Eisai INC. | $39.33 | 2019-2020 | |
| Caris Mpi, INC. | $31.20 | 2025 | Mi Cancer Seek |
| Astellas Pharma US INC | $24.98 | 2025 | Vyloy |
| Bayer Healthcare Pharmaceuticals INC. | $24.12 | 2019 | |
| Tactile Systems Technology INC | $21.07 | 2019 | |
| Karyopharm Therapeutics INC. | $20.86 | 2020 | |
| Glaxosmithkline, LLC. | $18.83 | 2024 | Ojjaara |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acrotech Biopharma INC. | $13.93 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $13.81 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elwyn Cabebe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.